Literature DB >> 9705868

Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein.

I Kukimoto1, S Aihara, K Yoshiike, T Kanda.   

Abstract

Oncoprotein E6 of the human papillomavirus (HPV) associated with cervical cancer (HPV-16 and -18) degrades tumor suppressor protein p53, but seems to have p53-independent transforming functions. We searched for other cellular targets for the N-terminal region of HPV-16 E6 using a yeast two-hybrid system. The E6 was found to bind to the C-terminal region of a human minichromosome maintenance 7 (hMCM7) protein, which is a component of replication licensing factors. The full-length hMCM7 translated in vitro was capable of binding to bacterially expressed E6. In yeast cells the E6s of the cancer-associated HPVs (HPV-16, -18, and -58) bound to hMCM7 more strongly than those of the HPVs associated with a benign tumor (HPV-6 and -11). Binding of E6 with hMCM7 may cause chromosomal abnormalities found in the human cells expressing E6s of oncogenic HPVs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705868     DOI: 10.1006/bbrc.1998.9066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Genetic variations in human papillomavirus and cervical cancer outcomes.

Authors:  Janet S Rader; Shirng-Wern Tsaih; Daniel Fullin; Miriam W Murray; Marissa Iden; Michael T Zimmermann; Michael J Flister
Journal:  Int J Cancer       Date:  2019-01-04       Impact factor: 7.396

2.  MCM proteins and checkpoint kinases get together at the fork.

Authors:  David Shechter; Jean Gautier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

Review 3.  Eukaryotic MCM proteins: beyond replication initiation.

Authors:  Susan L Forsburg
Journal:  Microbiol Mol Biol Rev       Date:  2004-03       Impact factor: 11.056

Review 4.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 5.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

6.  Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP.

Authors:  K Das; J Bohl; S B Vande Pol
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Interaction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation.

Authors:  Y Y Degenhardt; S Silverstein
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.

Authors:  Ajay Kumar; Yongtong Zhao; Gaoyuan Meng; Musheng Zeng; Seetha Srinivasan; Laurie M Delmolino; Qingshen Gao; Goberdhan Dimri; Georg F Weber; David E Wazer; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 9.  Papillomavirus E6 proteins.

Authors:  Heather L Howie; Rachel A Katzenellenbogen; Denise A Galloway
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

10.  Biomarkers in cervical cancer.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.